Your browser doesn't support javascript.
loading
Determination of proliferation index in neoplasms using different Ki-67 equivalent antibodies.
Lindboe, C F; von der Ohe, G; Torp, S H.
Afiliação
  • Lindboe CF; Department of Pathology, Vest-Agder Hospital, Kristiansand, Norway. c.lindboe@c2i.net
APMIS ; 111(5): 567-70, 2003 May.
Article em En | MEDLINE | ID: mdl-12887508
ABSTRACT
Paraffin sections from 23 tumours were immunohistochemically stained with the following four Ki-67 equivalent antibodies monoclonal MIB-1 (DAKO), monoclonal MM1 (Novocastra), polyclonal NCL-Ki-67p (Novocastra), and polyclonal Rah Ki-67 (DAKO). Ki-67 labelling indices were determined by counting in exactly the same area in each case. MIB-1 showed the highest labelling index in 21 of the 23 cases, and the mean MIB-1 index was approximately 30% higher than that of the other antibodies. The differences between MM1, NCL-Ki-67p and Rah Ki-67 were small and non-significant. There was a positive correlation between each of the four antibodies. As these findings may be of importance when the Ki-67 labelling index is used as a criterion for tumour grading or for clinical prognostication, this necessitate identification of the antibody used in every case.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Antígeno Ki-67 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2003 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Antígeno Ki-67 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2003 Tipo de documento: Article